News in brief

Thermo and Bio21 Institute to develop proof of concept lab

Picture: Bio21 Institute

The University of Melbourne’s Bio21 Institute has entered into an agreement with Thermo Fisher Scientific.

The collaboration is around developing a proof of concept lab to allow researchers to benchmark the latest mass spectrometric and UHPLC technologies, software, methodologies and workflows.

It will expand mass spectrometry, proteomics and lipidomics capabilities within the biomedical research precinct.

Thermo Fisher Scientific has revenues of $17bn and more than 50,000 employees in 50 countries. 

“The coming together of Thermo Fisher and the University of Melbourne’s Bio21 Institute allows us to draw from the considerable collective expertise that resides across both teams resulting in comprehensive solutions to complex research and pharmaceutical application challenges for our customers,” said Amit Agarwal, MD of Thermo Fisher Scientific, ANZ.

The Bio21 Institute opened in 2005 and is one of largest molecular science and biotechnology research centres in Australia, accommodating more than 550 researchers.

Professor Malcolm McConville, director, Bio21 Institute, said the collaboration between academic researchers and Thermo Fisher will result in exciting new applications and informatics tools.

“This collaboration represents an excellent opportunity to build capacity and ensure that University researchers have access to the latest mass spectrometry instrumentation and proteomics workflows in this fast evolving field.”

Professor James McCluskey, University of Melbourne’s deputy vice-chancellor (Research), said the university-industry partnership builds on existing investments.

“It will enable greater knowledge and technology transfer, and ensure Australian research is translated into positive health outcomes in the future.”

The Mass Spectrometry and Proteomics Facility (MSPF) is equipped with UHPLC (Ultra High Performance Liquid Chromatography), MALDI (Matrix Assisted Laser Desorption/Ionization), low resolution and ultra-high resolution mass spectrometry, for proteomic and chemical analysis.

Related News

The transaction is expected to close by the end of Q2 2016

Affymetrix acquisition strengthens biosciences – Thermo Fisher

DuPont BAX System Q7

Thermo Fisher and DuPont extend distribution agreement

One analyst said any potential deal was unlikely

Rumour of Thermo Fisher Scientific $30bn offer for Illumina

Dionex Integrion HPIC system

Thermo Fisher Scientific broadens specialist testing center

Thermo Scientific EA IsoLink IRMS system

Thermo Fisher Scientific targets elemental and isotope analysis

Related Products

See more related products

Submit a comment

Your comment has been saved

Post a comment

Please note that any information that you supply is protected by our Privacy and Cookie Policy. Access to all documents and request for further information are available to all users at no costs, In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information maybe shared with the owners of that document or information.